Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at a number of other media outlets and wouldn’t recommend the drug coverage at any of them. When not at Filter, she works with drug users in NYC and drug checkers in North Carolina to track hyperlocal supply changes, and cohosts a national stimulant users call with Isaac Jackson. She uses meth daily and other drugs sometimes.

    Fentanyl Cut With Xylazine Designated “Emerging Threat” by Feds

    On April 12, the White House Office of National Drug Control Policy (ONDCP) formally ...

    Meth Overamps Come in Two Forms. Mostly the One We Don’t Talk About.

    To people who don’t use meth, “overamp” means uncontrolled adrenaline. The term refers to ...

    Meth Harm Reduction and the Adderall Shortage

    For most of my 20s, running out of Adderall was the problem that put ...

    FDA Approves First Over-the-Counter Naloxone Product

    The Food and Drug Administration has approved the first over-the-counter (OTC) naloxone product, waiving ...

    FDA Inches Closer to OTC Narcan—at the Expense of Generic Naloxone

    Advisors to the Food and Drug Administration have voted unanimously in support of making ...

    SOTU: Biden Promises Fentanyl Crackdowns, OUD Meds in Prisons

    On February 7, President Joe Biden delivered the State of the Union address before ...

    DOJ Delays Safehouse Response to 2023, an Unexpected Blow

    The Department of Justice was expected to filed its long-awaited response to the ongoing ...

    Four States Close Prison Slavery Loopholes; Louisiana Votes Against

    Alabama, Oregon, Tennessee and Vermont have closed loopholes in their state constitutions that had ...

    FDA Exempts Harm Reduction From Biggest Naloxone Access Restrictions

    On September 22, the Food and Drug Administration announced that harm reduction naloxone suppliers ...